Rectal cancer, a subset of colorectal cancer, arises in the last several inches of the large intestine. Research into rectal cancer spans various domains, from early detection methods to innovative treatments. Screening through colonoscopies or fecal occult blood tests helps identify precancerous polyps or early-stage tumors, enhancing prognosis. Advances in imaging technologies like MRI and CT scans enable precise staging, guiding treatment decisions. Therapeutic approaches include surgery, chemotherapy, radiation therapy, and emerging immunotherapies tailored to individual genetic profiles. Targeted therapies, such as EGFR inhibitors, offer promising avenues for patients with specific genetic mutations. Moreover, ongoing studies explore the role of lifestyle modifications and dietary interventions in preventing rectal cancer development and recurrence. Comprehensive research efforts aim to improve outcomes and quality of life for individuals affected by this disease.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States